The FDA noted that Veronvy, a company that claims its products assist in weight loss and metabolism-boosting, said people on one of its products not only lost weight but also kept it off. In addition to a reduced-calorie diet and increased physical activity, Veronvy said its metabolic boost drops successfully helped people lose up to 52 pounds in three months during clinical trials and was approved by the Food and Drug Administration last year. The FDA said Veronvys products are intended to prevent, treat, or cure disease conditions and/or affect the structure or function of the body and categorized these supplements as unapproved drugs
Regardless of cause, if left unchecked, excess weight can contribute to chronic health conditions such as arthritis and other joint issues
It also helps the drug get absorbed into the bloodstream, allowing it to work effectively as a pill for the first time
Ingredients that are high in both protein and fiber are especially valuable on a GLP-1 weight loss journey
Tirzepatide tells a different story
For the Wegovy pill, the Phase 3 OASIS 4 trial demonstrated a mean weight loss of about 13.6% in the overall trial population and up to 16.6% among adherent patients over 64 weeks
